Louise Clune-Moriarty

Louise Clune-Moriarty is a notable inventor based in Quin, Ireland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that enhance the efficacy of widely used medications. Her work focuses on addressing the limitations of aspirin, a drug known for its anti-inflammatory and cardioprotective properties.

Latest Patents

Louise Clune-Moriarty holds 1 patent for her invention titled "Efficient aspirin prodrugs." This innovative technology aims to mitigate the gastrointestinal side effects associated with aspirin use, such as gastric bleeding. The prodrug compound she developed is designed to reduce contact between the drug and the intestinal lining, thereby enhancing its safety profile. The compound features a unique structure that includes various ester groups, which can be tailored to improve its therapeutic potential.

Career Highlights

Clune-Moriarty is affiliated with the Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth. Her academic and research endeavors have positioned her as a key figure in pharmaceutical innovation. Her dedication to improving drug safety and efficacy has garnered attention in the scientific community.

Collaborations

Louise has collaborated with esteemed colleagues, including John Francis Gilmer and Maeve Lally. These partnerships have facilitated the advancement of her research and the successful development of her patented technologies.

Conclusion

Louise Clune-Moriarty's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing medical challenges. Her work on efficient aspirin prodrugs not only enhances the safety of a widely used medication but also showcases the importance of continued research in drug development.

Profile summary based on public USPTO records.